Age Range
Patients who are 30-80 years old may participate
Study Criteria
Study participants should be diagnosed with early-stage Parkinson's disease (PD)
Treatments that reverse, stop, or slow down the progressive loss of neuron function in patients with Parkinson's disease do not currently exist.
The PRISM Parkinson's Research Study is evaluating an investigational drug to determine if it might slow down the progression of PD. By participating in this study, you could help advance the development of treatment options for this disease.
Do you know someone (ages 30 to 80) diagnosed with early-stage Parkinson’s disease (PD) who has not yet received medication for PD? They may be eligible to participate in this research study.